Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Citius Pharmaceuticals Q1 EPS $(0.02) Up From $(0.06) YoY

Citius Pharmaceuticals (NASDAQ:CTXR) reported quarterly losses of $(0.02) per share. This is a 66.67 percent increase over losses of $(0.06) per share from the same period last year.
byMichael Horton
February 10, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Citius Pharmaceuticals (NASDAQ:CTXR) reported quarterly losses of $(0.02) per share. This is a 66.67 percent increase over losses of $(0.06) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts